|
|
Volumn 343, Issue , 2011, Pages
|
|
Boehringer promoted off-label drug to patients, finds watchdog.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTITHROMBIN;
BENZIMIDAZOLE DERIVATIVE;
DABIGATRAN ETEXILATE;
PRESCRIPTION DRUG;
PYRIDINE DERIVATIVE;
ADVERTIZING;
DRUG INDUSTRY;
DRUG LEGISLATION;
ETHICS;
HUMAN;
NOTE;
OFF LABEL DRUG USE;
UNITED KINGDOM;
ADVERTISING AS TOPIC;
ANTITHROMBINS;
BENZIMIDAZOLES;
DRUG INDUSTRY;
GREAT BRITAIN;
HUMANS;
LEGISLATION, DRUG;
OFF-LABEL USE;
PRESCRIPTION DRUGS;
PYRIDINES;
|
|
EID: 84856319952
PISSN: None
EISSN: 14685833
Source Type: Journal
DOI: 10.1136/bmj.d8251 Document Type: Note |
|
Times cited : (2)
|
|
References (0)
|
